Amarin Corp Plc (AMRN)

[jessellivermore]

Thnx again Zum..

Really like this article. My feeling, as a clinician, is this one will really get picked up by the cardiologists. This paints Vascepa as "good stuff" in a real world scenario. Clinicians can relate to this and will be quick to extrapolate to include the entire problem of ischemia causing increased inflammation, and Vascepa being a safe drug to counter the problem.

Vascepa has been largely considered a preventative drug giving to patients with CVD risk. This article presents Vascepa in a new light, as an agent effective in acute situations. Patients who do not die immediately from AMIs but die subsequently from the event, die either from heart failure related to ventricular malfunction or ventricular arrhythmias. Cutting down on the arrhythmias is a big deal.

The company needs to get copies of this article to its sales reps for dissemination to the doctors.

":>) JL